Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis

被引：0
作者：
Antoine Leuzy
Irina Savitcheva
Konstantinos Chiotis
Johan Lilja
Pia Andersen
Nenad Bogdanovic
Vesna Jelic
Agneta Nordberg
机构：
[1] Karolinska Institutet,Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics Center for Alzheimer Research
[2] Karolinska University Hospital,Medical Radiation Physics and Nuclear Medicine
[3] Uppsala University,Department of Surgical Sciences, Radiology, Nuclear Medicine and PET
[4] Hermes Medical Solutions,Clinic for Cognitive Disorders, Theme Aging
[5] Karolinska University Hospital,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
[; F]Flutemetamol; Amyloid PET; Alzheimer’s disease; Diagnostic change; Cholinesterase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1276 / 1286
页数：10
相关论文
共 50 条
  • [21] FLUTEMETAMOL (18F): A β-AMYLOID POSITRON EMISSION TOMOGRAPHY TRACER FOR ALZHEIMER'S AND DEMENTIA DIAGNOSIS
    de Lartigue, J.
    DRUGS OF TODAY, 2014, 50 (03) : 219 - 229
  • [22] Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
    Westwood, Sarah
    Baird, Alison L.
    Hye, Abdul
    Ashton, Nicholas J.
    Nevado-Holgado, Alejo J.
    Anand, Sneha N.
    Liu, Benjamine
    Newby, Danielle
    Bazenet, Chantal
    Kiddle, Steven J.
    Ward, Malcolm
    Newton, Ben
    Desai, Keyur
    Hehir, Cristina Tan
    Zanette, Michelle
    Galimberti, Daniela
    Parnetti, Lucilla
    Lleo, Alberto
    Baker, Susan
    Narayan, Vaibhav A.
    van der Flier, Wiesje M.
    Scheltens, Philip
    Teunissen, Charlotte E.
    Visser, Pieter Jelle
    Lovestone, Simon
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [23] Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
    Dietmar Rudolf Thal
    Thomas G. Beach
    Michelle Zanette
    Johan Lilja
    Kerstin Heurling
    Aruna Chakrabarty
    Azzam Ismail
    Gill Farrar
    Christopher Buckley
    Adrian P. L. Smith
    Acta Neuropathologica, 2018, 136 : 557 - 567
  • [24] Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment
    Thurfjell, Lennart
    Lotjonen, Jyrki
    Lundqvist, Roger
    Koikkalainen, Juha
    Soininen, Hilkka
    Waldemar, Gunhild
    Brooks, David J.
    Vandenberghe, Rik
    NEURODEGENERATIVE DISEASES, 2012, 10 (1-4) : 246 - 249
  • [25] Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
    Si Eun Kim
    Byungju Lee
    Seongbeom Park
    Soo Hyun Cho
    Seung Joo Kim
    Yeshin Kim
    Hyemin Jang
    Jee Hyang Jeong
    Soo Jin Yoon
    Kyung Won Park
    Eun-Joo Kim
    Na Yeon Jung
    Bora Yoon
    Jae-Won Jang
    Jin Yong Hong
    Jihye Hwang
    Duk L. Na
    Sang Won Seo
    Seong Hye Choi
    Hee Jin Kim
    Alzheimer's Research & Therapy, 12
  • [26] Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project
    Collij, Lyduine E.
    Salvado, Gemma
    de Wilde, Arno
    Altomare, Daniele
    Shekari, Mahnaz
    Gispert, Juan Domingo
    Bullich, Santiago
    Stephens, Andrew
    Barkhof, Frederik
    Scheltens, Philip
    Bouwman, Femke
    van der Flier, Wiesje M.
    ALZHEIMERS & DEMENTIA, 2022, : 2397 - 2407
  • [27] Optimization of penalization function in Bayesian penalized likelihood reconstruction algorithm for [18F]flutemetamol amyloid PET images
    Fukuda, Shohei
    Wagatsuma, Kei
    Miwa, Kenta
    Yakushiji, Yu
    Kamitaka, Yuto
    Yamao, Tensho
    Miyaji, Noriaki
    Ishii, Kenji
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2024, 47 (04) : 1627 - 1637
  • [28] Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
    Hugh G. Pemberton
    Christopher Buckley
    Mark Battle
    Ariane Bollack
    Vrajesh Patel
    Petya Tomova
    David Cooke
    Will Balhorn
    Katherine Hegedorn
    Johan Lilja
    Christine Brand
    Gill Farrar
    EJNMMI Research, 13
  • [29] Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer's disease
    Lin, Huan-Chun
    Lin, Kun-Ju
    Huang, Kuo-Lun
    Chen, Shih-Hsin
    Ho, Tsung-Ying
    Huang, Chin-Chang
    Hsu, Jung-Lung
    Chang, Chiung-Chih
    Hsiao, Ing-Tsung
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [30] Impact of shortening time on diagnosis of 18F-florbetaben PET
    Trinh, Phuong T. H.
    Kim, Doo-Young
    Choi, Kang-Ho
    Kim, Jahae
    EJNMMI RESEARCH, 2024, 14 (01):
12345